Evidence map›Paper›PMID 39061688›Full record

ArticleDiagnostics (Basel, Switzerland)2024

Hybrid Positron Emission Tomography and Magnetic Resonance Imaging Guided Microsurgical Management of Glial Tumors: Case Series and Review of the Literature.

Yusuf Sukru Caglar, Murat Buyuktepe, Emre Yagiz Sayaci, Ihsan Dogan, Melih Bozkurt, Elif Peker, Cigdem Soydal, Elgin Ozkan, Nuriye Ozlem Kucuk

Abstract readCase Reports
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yusuf Sukru CaglarDepartment of Neurosurgery, Ankara University School of Medicine, 06230 Ankara, Turkey.
Murat BuyuktepeDepartment of Neurosurgery, Ankara University School of Medicine, 06230 Ankara, Turkey.ORCID 0000-0002-2599-8087
Emre Yagiz SayaciDepartment of Neurosurgery, Ankara University School of Medicine, 06230 Ankara, Turkey.
Ihsan DoganDepartment of Neurosurgery, Ankara University School of Medicine, 06230 Ankara, Turkey.
Melih BozkurtDepartment of Neurosurgery, Ankara University School of Medicine, 06230 Ankara, Turkey.
Elif PekerDepartment of Radiology, Ankara University School of Medicine, 06230 Ankara, Turkey.
Cigdem SoydalDepartment of Nuclear Medicine, Ankara University School of Medicine, 06230 Ankara, Turkey.
Elgin OzkanDepartment of Nuclear Medicine, Ankara University School of Medicine, 06230 Ankara, Turkey.
Nuriye Ozlem KucukDepartment of Nuclear Medicine, Ankara University School of Medicine, 06230 Ankara, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this case series, we aimed to report our clinical experience with hybrid positron emission tomography (PET) and magnetic resonance imaging (MRI) navigation in the management of recurrent glial brain tumors. Consecutive recurrent neuroglial brain tumor patients who underwent PET/MRI at preoperative or intraoperative periods were included, whereas patients with non-glial intracranial tumors including metastasis, lymphoma and meningioma were excluded from the study. A total of eight patients (mean age 50.1 ± 11.0 years) with suspicion of recurrent glioma tumor were evaluated. Gross total tumor resection of the PET/MRI-positive area was achieved in seven patients, whereas one patient was diagnosed with radiation necrosis, and surgery was avoided. All patients survived at 1-year follow-up. Five (71.4%) of the recurrent patients remained free of recurrence for the entire follow-up period. Two patients with glioblastoma had tumor recurrence at the postoperative sixth and eighth months. According to our results, hybrid PET/MRI provides reliable and accurate information to distinguish recurrent glial tumor from radiation necrosis. With the help of this differential diagnosis, hybrid imaging may provide the gross total resection of recurrent tumors without harming eloquent brain areas.

Indexed as

hybrid imagingmagnetic resonance imagingpositron emission tomographyradiation necrosisrecurrent glial tumor

Identifiers

PMID39061688
PMCPMC11275485

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.